{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T12:25:15Z","timestamp":1768652715913,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Roemex Ltd, Portlethen, UK"},{"name":"NIH","award":["HL30568"],"award-info":[{"award-number":["HL30568"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.bbalip.2013.12.010","type":"journal-article","created":{"date-parts":[[2013,12,22]],"date-time":"2013-12-22T18:00:13Z","timestamp":1387735213000},"page":"569-573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Upregulation of endogenous farnesyl diphosphate synthase overcomes the inhibitory effect of bisphosphonate on protein prenylation in Hela cells"],"prefix":"10.1016","volume":"1841","author":[{"given":"Subhajit","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie C.","family":"Crockett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.bbalip.2013.12.010_bb0005","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1359\/jbmr.06s216","article-title":"Acquired resistance to bisphosphonates in Paget's disease of bone","volume":"21","author":"Papapoulos","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0010","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1517\/14656566.2012.662486","article-title":"Pharmacotherapy of Paget's disease of bone","volume":"13","author":"Reid","year":"2012","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cncr.25529","article-title":"Zoledronic acid use in cancer patients: more than just supportive care?","volume":"117","author":"Coleman","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.bbalip.2013.12.010_bb0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjmed.2012.06.023","article-title":"Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday","volume":"126","author":"McClung","year":"2013","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bone.2010.11.008","article-title":"Biochemical and molecular mechanisms of action of bisphosphonates","volume":"49","author":"Rogers","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bbalip.2013.12.010_bb0180","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1359\/jbmr.2000.15.8.1467","article-title":"Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298","volume":"15","author":"Coxon","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0022-3565(24)38786-5","article-title":"Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates","volume":"296","author":"Dunford","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0040","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/1529-0131(200109)44:9<2201::AID-ART374>3.0.CO;2-E","article-title":"The molecular mechanism of action of the anti-resorptive and anti-inflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis","volume":"44","author":"Frith","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0045","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1124\/mol.59.2.193","article-title":"Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthetic pathway in a keratinocyte model for esophageal irritation","volume":"59","author":"Reszka","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0050","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1359\/jbmr.2003.18.2.204","article-title":"Antagonistic effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro","volume":"18","author":"Frith","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0055","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ijc.24758","article-title":"The bisphosphonate zoledronic acid has antimyeloma activity in vivo by inhibition of protein prenylation","volume":"126","author":"Guenther","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbalip.2013.12.010_bb0060","first-page":"263","article-title":"Pamidronate resistance and associated low ras levels in breast cancer cells: a role for combinatorial therapy","volume":"34","author":"Zhang","year":"2004","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0065","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1002\/art.11136","article-title":"Bisphosphonate resistance in Paget's disease of bone","volume":"48","author":"Joshua","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0070","first-page":"4031","article-title":"In vitro evaluation of zoledronic acid resistance developed in MCF-7 cells","volume":"27","author":"Kars","year":"2007","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0075","first-page":"3565","article-title":"Inhibition of heat-shock protein 27 expression eliminates drug resistance of osteosarcoma to zoledronic acid","volume":"30","author":"Morii","year":"2010","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0080","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1359\/jbmr.2000.15.5.971","article-title":"The intracellular target for the antiresorptive aminobisphosphonate drugs in Dictyostelium discoideum is the enzyme farnesyl diphosphate synthase","volume":"15","author":"Grove","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0085","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1046\/j.1365-2141.2003.04437.x","article-title":"How myeloma cells escape bisphosphonate-mediated killing: development of specific resistance with preserved sensitivity to conventional chemotherapeutics","volume":"122","author":"Salomo","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0090","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1582-4934.2008.00141.x","article-title":"Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells","volume":"12","author":"Ory","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0095","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)80213-5","article-title":"The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor","volume":"89","author":"Brown","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bbalip.2013.12.010_bb0100","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1016\/S0021-9258(19)39606-1","volume":"265","author":"Wilkin","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0105","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1042\/BJ20091511","article-title":"Sterol-regulatory-element-binding protein 2 and nuclear factor Y control human farnesyl diphosphate synthase expression and affect cell proliferation in hepatoblastoma cells","volume":"429","author":"Ishimoto","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0110","doi-asserted-by":"crossref","first-page":"14165","DOI":"10.1016\/S0021-9258(17)36769-8","article-title":"Farnesyl-diphosphate synthase is localized in peroxisomes","volume":"269","author":"Krisans","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ymgme.2003.12.001","article-title":"Human mevalonate pyrophosphate decarboxylase is localized in the cytosol","volume":"81","author":"Hogenboom","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0120","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1042\/BJ20120750","article-title":"Farnesyl diphosphate synthase, the target for nitrogen-containing bisphosphonate drugs, is a peroxisomal enzyme in the model system Dictyostelium discoideum","volume":"447","author":"Nuttall","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0125","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.exppara.2008.02.013","article-title":"Farnesyl diphosphate synthase localizes to the cytoplasm of Trypanosoma cruzi and T. brucei","volume":"119","author":"Ferella","year":"2008","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0130","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.bbamcr.2006.11.015","article-title":"Mitochondrial targeting of farnesyl diphosphate synthase is a widespread phenomenon in eukaryotes","volume":"1773","author":"Martin","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2013.12.010_bb0135","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0092-8674(01)00310-5","article-title":"The human peroxisomal targeting signal receptor, Pex5p, is translocated into the peroxisomal matrix and recycled to the cytosol","volume":"105","author":"Dammai","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.bbalip.2013.12.010_bb0140","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1359\/jbmr.091009","article-title":"Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo","volume":"25","author":"Roelofs","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0145","doi-asserted-by":"crossref","first-page":"26983","DOI":"10.1016\/S0021-9258(19)74207-0","article-title":"Effect of site-directed mutagenesis of conserved aspartate and arginine residues upon farnesyl diphosphate synthase activity","volume":"268","author":"Joly","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0150","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/S0022-2275(20)39114-8","article-title":"Role for sterol regulatory element binding protein in the regulation of farnesyl diphosphate synthase and in the control of cellular levels of cholesterol and triglyceride: evidence from sterol regulation-defective cells","volume":"37","author":"Jackson","year":"1996","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0155","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1073\/pnas.93.2.945","article-title":"Sterol regulatory element binding protein binds to a cis element in the promoter of the farnesyl diphosphate synthase gene","volume":"93","author":"Ericsson","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0160","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ygeno.2008.11.002","article-title":"Characterization and functional analysis of cis-acting elements of the human farnesyl diphosphate synthetase (FDPS) gene 5\u2032 flanking region","volume":"93","author":"Romanelli","year":"2009","journal-title":"Genomics"},{"key":"10.1016\/j.bbalip.2013.12.010_bb0165","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1172\/JCI119247","article-title":"Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells","volume":"99","author":"Shimomura","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2013.12.010_bb0170","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.maturitas.2007.01.005","article-title":"Farnesyl diphosphate synthase: a novel genotype association with bone mineral density in elderly women","volume":"57","author":"Levy","year":"2007","journal-title":"Maturitas"},{"key":"10.1016\/j.bbalip.2013.12.010_bb0175","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/tpj.2010.88","article-title":"Common allelic variants of the farnesyl diphosphate synthase gene influence the response of osteoporotic women to bisphosphonates","volume":"12","author":"Olmos","year":"2012","journal-title":"Pharmacogenomics J."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198113002837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198113002837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T08:43:34Z","timestamp":1746089014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198113002837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1388198113002837"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2013.12.010","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upregulation of endogenous farnesyl diphosphate synthase overcomes the inhibitory effect of bisphosphonate on protein prenylation in Hela cells","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2013.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}